SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about record date

07 Feb 2020 Evaluate

Sun Pharmaceutical Industries has informed that the Company has fixed February 18, 2020 as the Record Date for the purpose of Payment of Interim Dividend. The payment of the interim dividend would be made to the eligible shareholders on or before February 24, 2020.

The above information is a part of company's filings submitted to BSE.

Sun Pharma. Inds. Share Price

1911.20 39.65 (2.12%)
03-Jul-2026 12:55 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1911.20
Dr. Reddys Labs. 1385.90
Cipla 1463.35
Zydus Lifesciences 1132.55
Lupin 2472.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: